The Enterprise Value as of November 2025 (TTM) for Sorrento Therapeutics, Inc. (SRNEQ) is 112.78M

According to Sorrento Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 112.78M. This represents a change of -8.40% compared to the average of 123.11M of the last 4 quarters.

Sorrento Therapeutics, Inc. (SRNEQ) Historical Enterprise Value (quarterly & annually)

How has SRNEQ Enterprise Value performed in the past?

The mean historical Enterprise Value of Sorrento Therapeutics, Inc. over the last ten years is 64.39M. The current 112.78M Enterprise Value has changed 17.42% with respect to the historical average. Over the past ten years (40 quarters), SRNEQ's Enterprise Value was at its highest in in the September 2019 quarter at 284.79M. The Enterprise Value was at its lowest in in the June 2016 quarter at -88707112.00.

Sorrento Therapeutics, Inc. (SRNEQ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sorrento Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sorrento Therapeutics, Inc. (SRNEQ) Average Enterprise Value

How has SRNEQ Enterprise Value performed in the past?

The current Enterprise Value of Sorrento Therapeutics, Inc. (SRNEQ) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Sorrento Therapeutics, Inc. (SRNEQ) Enterprise Value vs. Peers

How is SRNEQ’s Enterprise Value compared to its peers?

Sorrento Therapeutics, Inc.’s Enterprise Value is less than American Hemp Ventures, Inc. (0), greater than Malachite Innovations, Inc. (-884137.00), greater than Noxopharm Limited (28.10M), greater than Avecho Biotechnology Limited (17.86M), greater than Rapid Dose Therapeutics Corp. (26.58M), greater than OKYO Pharma Limited (74.04M), greater than Poxel S.A. (57.20M), greater than Ceapro Inc. (-5906285.00), greater than Organicell Regenerative Medicine, Inc. (19.78M), greater than Eiger BioPharmaceuticals, Inc. (28.35M),

Build a custom stock screener for Sorrento Therapeutics, Inc. (SRNEQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sorrento Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sorrento Therapeutics, Inc. (SRNEQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sorrento Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.